Hsu Jason's Form 4 filing
Immix Biopharma, Inc. (IMMX) · filed Dec 12, 2023
- Accession no.
- 0001493152-23-044618
- Filed
- Dec 12, 2023
- Trade date
- Dec 8-11, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $266.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hsu JasonCIK 0001895035 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2023 | Common Stock | PPurchaseAcquired | +25,000 | $4.88 | +$122,000 | 782,000 | Direct | |
| Dec 11, 2023 | Common Stock | PPurchaseAcquired | +31,000 | $4.67 | +$144,770 | 813,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.